Latest Whitepapers

Download this whitepaper to learn more about mRNA therapeutics including how they could treat genetic diseases and cancer, the challenges associated with delivery and dosage as well as how to avoid an unwanted immune response.

In this cell and gene therapy insights expert roundtable, a panel of four experts will answer some central questions surrounding the development of novel biotherapeutics.

The quality of indoor air dramatically affects the health of animals and humans during livestock production. Airborne transmission has been suspected of being responsible for epidemics of highly infectious diseases in livestock production, and due to the COVID-19 pandemic, there has been increasing concern about the role of wild animals in the epidemiology of most zoonoses.

With time a precious commodity and ever-increasing regulatory scrutiny, pharmaceutical laboratories are always on the lookout for simple solutions to make their routine tasks easier.

Gene therapy is rapidly gaining importance as a critical treatment modality in the prevention or cure of a wide range of diseases. However, getting a product to market for commercial use does not come without its challenges.

Adeno-associated virus (AAV) has shown great potential as a delivery vector for therapeutic genes and is becoming a tool of choice for many emerging gene therapies.

Screening tests are intended to identify infected individuals who may be contagious, regardless of whether they are displaying symptoms, so that measures can be taken to prevent those individuals from infecting others.

Download this whitepaper to discover how a cell sorter can provide precise sorting while maintaining low droplet charge voltages and also handle very high event and sort rates.

Download this whitepaper to discover how third generation sequencing can identify disease-causing variants with complex genetic etiology, detect SARS-CoV-2 and provide novel genetic insights.

Many regulatory guidelines state that cell banks and cultures used in the production of biologics must be tested for mycoplasma. Mycoplasma infections can cause severe problems in manufacturing as these organisms can alter DNA, RNA and modify host cell plasma membrane antigens.